Navigation Links
Omthera Announces Waiver of Lock-Up Restriction
Date:7/11/2013

mpleted pharmacokinetic and Phase III clinical studies to investigate the safety and efficacy profile of Epanova™. In 2012 the Company reported positive results from its Phase III EVOLVE and ESPRIT trials, both of which were conducted under SPA agreements with the U.S. Food and Drug Administration. Omthera holds worldwide rights to Epanova™ under a license from Chrysalis Pharma AG, a privately held Swiss company that is the owner of the product. For more information, please visit http://www.omthera.com.

Important Information and Where to Find It

On June 13, 2013, the Company filed with the Securities and Exchange Commission (the "SEC") a definitive proxy statement in connection with the proposed transaction (the "Definitive Proxy Statement") and, on June 14, 2013, the Company commenced mailing of the Definitive Proxy Statement to its stockholders.  INVESTORS AND THE COMPANY'S STOCKHOLDERS ARE URGED TO READ THE DEFINITIVE PROXY STATEMENT AND ANY OTHER RELEVANT DOCUMENTS FILED WITH THE SEC WHEN THEY BECOME AVAILABLE BECAUSE THEY CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION AND THE COMPANY.  Investors and stockholders may obtain free copies of the Definitive Proxy Statement and other documents (when available) that the Company files with the SEC at the SEC's website at http://www.sec.gov.  In addition, the Definitive Proxy Statement and other documents filed by the Company with the SEC may be obtained from the Company free of charge by directing a request to Omthera Pharmaceuticals, Inc., Attn: Christian S. Schade, Executive Vice President and Chief Financial Officer, 707 State Road, Princeton, New Jersey 08540.

Certain Information Concerning Participants

The Company and its directors and executive officers and certain other persons may be deemed to be partici
'/>"/>

SOURCE Omthera Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Omthera Pharmaceuticals Announces Record Date and Meeting Date for Special Meeting of Stockholders
2. Omthera Pharmaceuticals, Inc. Stockholders Seeking More Money, Information in Buyout Should Contact Deans & Lyons Law Firm
3. Omthera Pharmaceuticals Announces First Quarter 2013 Financial Results
4. Covington Advises Omthera Pharmaceuticals on Merger with AstraZeneca
5. Omthera Pharmaceuticals, Inc. Announces Closing of Initial Public Offering
6. Omthera Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering
7. Omthera Pharmaceuticals Presents Data From Analysis Of EVOLVE Trial Showing That Epanova Lowers ApoC-III, A Key Predictor of Cardiovascular Risk
8. Omthera Pharmaceuticals Announces Invitation to Attend Presentation of the Complete Data Sets from its Phase 3 EVOLVE and ESPRIT Clinical Studies
9. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
10. CryoLife Announces Release Date and Teleconference Call Details for 2013 Second Quarter Financial Results
11. UM Ventures Announces Collaboration Between UM School Of Medicines Dr. Frank Robb and Fina Biosolutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... 2015   Eraser Clinic Laser Tattoo Removal in ... removal specialty clinic in the area to offer laser tattoo ... ink clearance and can treat the widest range of ink ... blue. "Our focus at Eraser Clinic is ... the nation – and that happens by giving our clients ...
(Date:4/1/2015)... , April 1, 2015  Salix Pharmaceuticals, Ltd. ... wholly owned subsidiary of Valeant Pharmaceuticals International, Inc. (NYSE: ... provided a Notice of Fundamental Changes, Make-Whole Fundamental Changes ... Execution of Supplemental Indenture and Offer to Purchase (the ... Senior Notes due 2015 (the " Notes "), pursuant ...
(Date:4/1/2015)... YORK , April 1, 2015  New York ... their world class Intellectual Properties portfolio with U.S. Patent ... Properties policy. This patent represents a surgical instrument that ... seeing as if it were in the traditional format ... match it against medical databases during surgery, thus providing ...
Breaking Medicine Technology:Eraser Clinic Is The First To Offer Trinity Laser Tattoo Removal In Austin, TX 2Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 2.75% Convertible Senior Notes Due 2015 2Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 2.75% Convertible Senior Notes Due 2015 3Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 2.75% Convertible Senior Notes Due 2015 4Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 2.75% Convertible Senior Notes Due 2015 5Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 2.75% Convertible Senior Notes Due 2015 6Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 2.75% Convertible Senior Notes Due 2015 7Ground-Breaking Surgical Instrument Allows Surgeons to obtain Real Time Biopsies 2Ground-Breaking Surgical Instrument Allows Surgeons to obtain Real Time Biopsies 3
... 2011 Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ) ... will be presenting at the Lazard Capital Markets 8th Annual ... York City. Mr. Bentsur,s presentation is scheduled to take place ... A live audio webcast of Mr. Bentsur,s presentation will ...
... PHILADELPHIA, Nov. 11, 2011 Booth # 407 ... Week 2011 -- NxStage® Medical, Inc. (Nasdaq: ... dialysis products, today announced that its Medisystems division ... Vasc-Alert™ Access Surveillance Solution to Atlantic Dialysis Management ...
Cached Medicine Technology:Keryx Biopharmaceuticals to Present at Lazard Capital Markets 8th Annual Healthcare Conference 2NxStage Awarded Multi-Year Contract to Supply Atlantic Dialysis Management Services with Vasc-Alert Access Surveillance Solution 2NxStage Awarded Multi-Year Contract to Supply Atlantic Dialysis Management Services with Vasc-Alert Access Surveillance Solution 3
(Date:4/1/2015)... After a particularly harsh winter, many roads are ... to costly damage, so Amica Insurance has tips ... following suggestions from AAA: , , Inspect ... to the manufacturer’s recommended levels. , ... uneven tire wear can be signs of bad shocks or ...
(Date:4/1/2015)... Taking an important step forward in the continuing ... for Nursing Education Accreditation (NLN CNEA) , the League’s ... Board of Commissioners. Working with executive director Judith A. ... provide leadership and direction to accreditation services and will ... programs that seek accreditation from the CNEA. , “The ...
(Date:4/1/2015)... BioPlus Specialty Pharmacy (BioPlus), ... released a new app to keep health care providers ... hepatitis C virus (HCV) infection. This ‘HCV Treatment Path’ ... the American Association for the Study of Liver Diseases ... direct-acting oral medications to treat HCV have been approved ...
(Date:4/1/2015)... Seattle, WA (PRWEB) April 01, 2015 ... management and patient scheduling platform, today announced that CEO ... 2015 Annual HIMSS Conference & Exhibition in ... Outpatient Revenue Growth with Better Provider Care Coordination Strategies ... April 16 at 12 p.m. CDT. More than 38,000 ...
(Date:4/1/2015)... Parents of teenaged and adolescent children might want ... post discusses Teen Violence Related to Substance Abuse. As ... Awareness Month, the substance abuse treatment center has issued ... identify if there may be problems with their kids ... alcohol. , “People learn how to establish healthy relationships ...
Breaking Medicine News(10 mins):Health News:Prepare for potholes with 7 tips from Amica Insurance 2Health News:NLN Commission for Nursing Education Accreditation (NLN CNEA) Announces Inaugural Commissioners 2Health News:NLN Commission for Nursing Education Accreditation (NLN CNEA) Announces Inaugural Commissioners 3Health News:BioPlus Specialty Pharmacy Releases ‘HCV Treatment Path’ App for Hepatitis C Providers 2Health News:SCI Solutions CEO Joel French and Northeast Georgia Health System to Present at HIMSS15 2Health News:SCI Solutions CEO Joel French and Northeast Georgia Health System to Present at HIMSS15 3Health News:SCI Solutions CEO Joel French and Northeast Georgia Health System to Present at HIMSS15 4Health News:Best Drug Rehabilitation Issues Toolkit for Teen Violence Related to Substance Abuse 2
... , American Academy ... , ROSEMONT, Ill., July 23 The American Academy ... a nonprofit organization dedicated to collecting and reporting on hip and knee ... best practice. , , The goal ...
... July 23 /PRNewswire-FirstCall/ - Hard to Treat Diseases, ... in its Slavica BioChem division have advised of ... use of Ribavirin in the treatment of Multiple ... conducting experiments using Dark Agouti rats. Experimental ...
... , ROANOKE, Va., July 23 Job ... The Virginia Psychological Association (VPA) and Virginia Academy of Clinical ... this cost by awarding the 2009 VPA/VACP Psychologically Healthy Workplace ... submit nominations. , , ...
... , , SPOKANE, ... in partnership with eHealth Initiative will hold the Northwest ... featuring national and regional speakers on September 10 and ... and rural healthcare professionals to learn about the latest ...
... Medical Technologies, Inc. (Nasdaq: PMTI ), a leading ... hold its quarterly conference call of its 2009 second quarter ... Eastern Time. If you would like to participate, please call ... The telephone replay will be available one hour after the ...
... read my mind, love, what a tale my thoughts could ... people,s minds? Some researchers, and some new businesses, are banking ... imaging (fMRI) to reveal hidden thoughts, such as lies, truths ... neuroscientists at UCLA and Rutgers University provides evidence that fMRI ...
Cached Medicine News:Health News:American Joint Replacement Registry Announced 2Health News:Hard to Treat Diseases, Inc. (HTDS) Reports on Ribavirin Research as Potential Treatment for MS 2Health News:Hard to Treat Diseases, Inc. (HTDS) Reports on Ribavirin Research as Potential Treatment for MS 3Health News:INHS Brings Health Information Technology Conference to Spokane 2Health News:Palomar Medical Technologies To Host Second Quarter 2009 Financial Results Conference Call and Webcast on July 30, 2009 2Health News:Can brain scans read your mind? 2Health News:Can brain scans read your mind? 3
Inquire...
Inquire...
One Pair of Knife Raising Blocks to move blade up 1 inch for adpatation of a freezing stage....
Supercassette quick release holder for the 8000 Series sliding microtome to allow for the use of wax supercassettes, 75x52x19 mm....
Medicine Products: